1. Home
  2. GBIO vs CENN Comparison

GBIO vs CENN Comparison

Compare GBIO & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • CENN
  • Stock Information
  • Founded
  • GBIO 2016
  • CENN 2013
  • Country
  • GBIO United States
  • CENN United States
  • Employees
  • GBIO N/A
  • CENN N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • CENN Auto Manufacturing
  • Sector
  • GBIO Health Care
  • CENN Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • CENN Nasdaq
  • Market Cap
  • GBIO 29.2M
  • CENN 30.4M
  • IPO Year
  • GBIO 2020
  • CENN N/A
  • Fundamental
  • Price
  • GBIO $0.35
  • CENN $0.65
  • Analyst Decision
  • GBIO Strong Buy
  • CENN
  • Analyst Count
  • GBIO 4
  • CENN 0
  • Target Price
  • GBIO $7.33
  • CENN N/A
  • AVG Volume (30 Days)
  • GBIO 1.1M
  • CENN 373.8K
  • Earning Date
  • GBIO 08-06-2025
  • CENN 08-12-2025
  • Dividend Yield
  • GBIO N/A
  • CENN N/A
  • EPS Growth
  • GBIO N/A
  • CENN N/A
  • EPS
  • GBIO N/A
  • CENN N/A
  • Revenue
  • GBIO $24,556,000.00
  • CENN $31,097,533.00
  • Revenue This Year
  • GBIO N/A
  • CENN N/A
  • Revenue Next Year
  • GBIO N/A
  • CENN N/A
  • P/E Ratio
  • GBIO N/A
  • CENN N/A
  • Revenue Growth
  • GBIO 146.47
  • CENN 234.45
  • 52 Week Low
  • GBIO $0.30
  • CENN $0.64
  • 52 Week High
  • GBIO $3.65
  • CENN $1.84
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 44.93
  • CENN 42.17
  • Support Level
  • GBIO $0.32
  • CENN $0.69
  • Resistance Level
  • GBIO $0.36
  • CENN $0.76
  • Average True Range (ATR)
  • GBIO 0.03
  • CENN 0.09
  • MACD
  • GBIO -0.00
  • CENN -0.01
  • Stochastic Oscillator
  • GBIO 35.27
  • CENN 16.22

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.

Share on Social Networks: